β-Nicotyrine
(Synonyms: 二烯烟碱,α-Nicotyrine,NSC 127943,NSC 407276) 目录号 : GC15056A metabolite of nicotine
Cas No.:487-19-4
Sample solution is provided at 25 µL, 10mM.
β-Nicotyrine is an alkaloid metabolite of nicotine as well as a major product of its pyrolysis.[1],[2] It binds comparably to two cytochrome P450 (CYP) isoforms, CYP2A6 and CYP2A13 (Kis = 7.5 and 5.6 µM, respectively), which are prominently involved in the metabolism of xenobiotics in the airways.[3] However, β-nicotyrine appears to more effectively inactivate CYP2A6, leaving only 49% activity after a 10 minute exposure with 20 µM β-nicotyrine, as opposed to 87% remaining activity for CYP2A13 treated identically.[4] Presumably through this effect, β-nicotyrine inhibits DNA strand breaks induced by the genotoxic tobacco metabolite (4-(methylnitrosamino)-1-(2-pyridyl)-1-butanone), which is bioactivated by CYP2A isoforms.[5]
Reference:
[1]. Swain, M.L., Eisner, A., Woodward, C.F., et al. Ultraviolet absorption spectra of nicotine, nornicotine and some of their derivatives. Journal of the American Chemical Society 71(4), 1341-1345 (1949).
[2]. Clayton, P., Lu, A., and Bishop, L. The pyrolysis of (−)-(S)-nicotine: Racemization and decomposition. Chirality 22(4), 442-446 (2010).
[3]. Stephens, E.S., Walsh, A.A., and Scott, E.E. Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. Drug Metabolism and Disposition 40(9), 1797-1802 (2012).
[4]. Kramlinger, V.M., von Weymarn, L.B., and Murphy, S.E. Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol. Chemico-Biological Interactions 197(2-3), 87-92 (2012).
[5]. Ordonez, P., Sierra, A.B., Camacho, O.M., et al. Nicotine, cotinine, and β-nicotyrine inhibit NNK-induced DNA-strand break in the hepatic cell line HepaRG. Toxicol.In Vitro 28(2014), 1329-1337 (2014).
Cas No. | 487-19-4 | SDF | |
别名 | 二烯烟碱,α-Nicotyrine,NSC 127943,NSC 407276 | ||
化学名 | 3-(1-methyl-1H-pyrrol-2-yl)-pyridine | ||
Canonical SMILES | CN1C=CC=C1C2=CC=CN=C2 | ||
分子式 | C10H10N2 | 分子量 | 158.2 |
溶解度 | ≤50mg/ml in ethanol;30mg/ml in DMSO;50mg/ml in dimethyl formamide | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 6.3211 mL | 31.6056 mL | 63.2111 mL |
5 mM | 1.2642 mL | 6.3211 mL | 12.6422 mL |
10 mM | 0.6321 mL | 3.1606 mL | 6.3211 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet